01.07.2015 • NewsDede WillamsPeopleAltana

Babilas to Become New Altana Chief

Martin Babilas will become the new chief executive of German chemical producer Altana upon the retirement of Matthias L. Wolfgruber on January 1, 2016.
The 43-year-old executive took over additional responsibility for two of the Bad Homburg-based company’s four divisions from the CEO in November of last year. On stepping into the new job Babilas also will take over responsibility for Corporate Development/M&A, Human Resources, Corporate Communications and Internal Audit from the 61-year-old Wolfgruber.
Effective Aug. 1, 2015, Altana will also have a new chief financial officer, Stefan Genten. The 46-year-old will move from German pharmaceutical producer Grünenthal, where he held the same position since 2005. Genten was also in charge of operative functions, such as the Latin American business, and was appointed chief operating officer in 2010.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read